精神分裂症电治疗中的代谢机制:作用,潜力和未来方向
1Mental Health Center, Kunming Medical University, Kunming 650034, China.
International journal of molecular sciences
|February 27, 2026
概括
电疗法 (ECT) 可以通过调节新陈代谢,免疫力和神经内分泌系统来治疗精神分裂症. 这项研究探讨了ECT.
科学领域:
- 神经科学是一个神经科学.
- 代谢研究研究 代谢研究
- 精神病学是一个精神病学.
背景情况:
- 精神分裂症表现出一种独特的代谢表型,涉及葡萄糖,脂质,氨基酸和核酸.
- 精神分裂症的病理途径包括能量失衡,氧化还原应激,免疫激活和神经递质异常.
- 代谢物是精神分裂症诊断和监测的潜在生物标志物.
研究的目的:
- 提出一种集成的"新陈代谢-免疫-神经内分泌"假设,用于精神分裂症的电疗法 (ECT).
- 通过代谢重编程阐明ECT抗精神病作用的分子基础.
- 将ECT的代谢效应与抗精神病药物和其他疗法进行比较.
主要方法:
- 分析"新陈代谢-免疫-神经内分泌"轴对ECT的反应.
- 对受ECT,抗精神病药物和其他疗法 (rTMS,tDCS) 影响的代谢网络进行比较分析.
- 研究抑郁症和双相情感障碍中的代谢调节.
主要成果:
- ECT显示了对神经发生,免疫平衡和下丘脑-垂体-目标腺轴的调节作用.
- 电感治疗会影响大脑和外周代谢.
- 代谢重编程被假设是ECT抗精神病作用的基础.
结论:
- "新陈代谢-免疫-神经内分泌"假设为了解精神分裂症中ECT的机制提供了一个框架.
- 代谢洞察力可能会导致新的生物标志物和精确精神病学治疗点.
- 了解精神疾病中的代谢调节可以为治疗策略提供信息.
相关概念视频
Electroconvulsive Therapy
1.5K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.5K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K
Psychosis: Goals of Pharmacotherapy
642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
Biological Causes of Schizophrenia
809
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
809
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K


